Last 12 months
Inside the activity.
0 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 23, 2024 Filed Jan 26, 2024 02:17 UTC |
Furey Raymond J.EVP, GC, CCO & Corp Sec
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 157,000 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0000905148-24-000309 · form4.xml · derivative · entry 2 Furey Raymond J. · CIK 0001577899 · EVP, GC, CCO & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 157,000 Underlying: Common Stock · 157,000 shares Expires 2034-01-23 F3 · derivative.exercise_date: The shares of common stock subject to the option vest monthly over three (3) years from the vesting commencement date of January 23, 2024, subject to the Reporting Person's continuous service to the issuer through each such period. Read SEC document |
| January 23, 2024 Filed Jan 26, 2024 02:17 UTC |
Furey Raymond J.EVP, GC, CCO & Corp Sec
|
GrantCommon Stock | 209,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-24-000309 · form4.xml · nonDerivative · entry 1 Furey Raymond J. · CIK 0001577899 · EVP, GC, CCO & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 214,000 F1 · shares: The shares of common stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall vest annually over three (3) years from February 1, 2024, with the first annual vest occurring on February 1, 2025. F2 · balance_after: Includes 5,000 shares acquired under the Issuer's stock purchase plan. Read SEC document |
| January 23, 2024 Filed Jan 26, 2024 02:16 UTC |
Schorno Dean LEVP & Chief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 157,000 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0000905148-24-000306 · form4.xml · derivative · entry 2 Schorno Dean L · CIK 0001509688 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 157,000 Underlying: Common Stock · 157,000 shares Expires 2034-01-23 F3 · derivative.exercise_date: The shares of common stock subject to the option vest monthly over three (3) years from the vesting commencement date of January 23, 2024, subject to the Reporting Person's continuous service to the issuer through each such period. Read SEC document |
| January 23, 2024 Filed Jan 26, 2024 02:16 UTC |
Schorno Dean LEVP & Chief Financial Officer
|
GrantCommon Stock | 209,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-24-000306 · form4.xml · nonDerivative · entry 1 Schorno Dean L · CIK 0001509688 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 415,519 F1 · shares: The shares of common stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall vest annually over three (3) years from February 1, 2024, with the first annual vest occurring on February 1, 2025. F2 · balance_after: Includes 10,000 shares acquired under the Issuer's stock purchase plan. Read SEC document |
| January 23, 2024 Filed Jan 26, 2024 02:17 UTC |
RODRIGUEZ RAUL RDirector · CEO, President
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 600,000 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0000905148-24-000308 · form4.xml · derivative · entry 2 RODRIGUEZ RAUL R · CIK 0001190279 · Director · CEO, President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 600,000 Underlying: Common Stock · 600,000 shares Expires 2034-01-23 F3 · derivative.exercise_date: The shares of common stock subject to the option vest monthly over three (3) years from the vesting commencement date of January 23, 2024, subject to the Reporting Person's continuous service to the issuer through each such period. Read SEC document |
| January 23, 2024 Filed Jan 26, 2024 02:17 UTC |
RODRIGUEZ RAUL RDirector · CEO, President
|
GrantCommon Stock | 400,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-24-000308 · form4.xml · nonDerivative · entry 1 RODRIGUEZ RAUL R · CIK 0001190279 · Director · CEO, President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,089,523 F1 · shares: The shares of common stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall vest annually over three (3) years from February 1, 2024, with the first annual vest occurring on February 1, 2025. F2 · balance_after: Includes 8,810 shares acquired under the Issuer's stock purchase plan. Read SEC document |
| January 23, 2024 Filed Jan 26, 2024 02:17 UTC |
Santos David AEVP, Chief Commercial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 157,000 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0000905148-24-000307 · form4.xml · derivative · entry 2 Santos David A · CIK 0001820066 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 157,000 Underlying: Common Stock · 157,000 shares Expires 2034-01-23 F3 · derivative.exercise_date: The shares of common stock subject to the option vest monthly over three (3) years from the vesting commencement date of January 23, 2024, subject to the Reporting Person's continuous service to the issuer through each such period. Read SEC document |
| January 23, 2024 Filed Jan 26, 2024 02:17 UTC |
Santos David AEVP, Chief Commercial Officer
|
GrantCommon Stock | 209,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-24-000307 · form4.xml · nonDerivative · entry 1 Santos David A · CIK 0001820066 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 363,612 F1 · shares: The shares of common stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall vest annually over three (3) years from February 1, 2024, with the first annual vest occurring on February 1, 2025. F2 · balance_after: Includes 10,000 shares acquired under the Issuer's stock purchase plan. Read SEC document |
| May 26, 2023 Filed Jul 12, 2023 22:45 UTC |
LAPOINTE ANTHONY GREGGDirector
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $1.32 | $0.00 |
DisclosureSEC source: 0001140361-23-034286 · form4.xml · derivative · entry 2 LAPOINTE ANTHONY GREGG · CIK 0001331860 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2033-05-26 F2 · derivative.exercise_date: The shares vest monthly over one (1) year from the date of grant, subject to the Reporting Person's continuous service on the Company's Board of Directors. Read SEC document |
| May 26, 2023 Filed Jul 12, 2023 22:45 UTC |
LAPOINTE ANTHONY GREGGDirector
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-034286 · form4.xml · nonDerivative · entry 1 LAPOINTE ANTHONY GREGG · CIK 0001331860 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 F1 · shares: The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors. Read SEC document |
| May 26, 2023 Filed Jul 12, 2023 22:45 UTC |
MOOS WALTER HDirector
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $1.32 | $0.00 |
DisclosureSEC source: 0001140361-23-034285 · form4.xml · derivative · entry 2 MOOS WALTER H · CIK 0001190272 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2033-05-26 F2 · derivative.exercise_date: The shares vest monthly over one (1) year from the date of grant, subject to the Reporting Person's continuous service on the Company's Board of Directors. Read SEC document |
| May 26, 2023 Filed Jul 12, 2023 22:45 UTC |
MOOS WALTER HDirector
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-034285 · form4.xml · nonDerivative · entry 1 MOOS WALTER H · CIK 0001190272 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,222 F1 · shares: The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors. Read SEC document |
| May 26, 2023 Filed Jul 12, 2023 22:45 UTC |
Wasman JaneDirector
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $1.32 | $0.00 |
DisclosureSEC source: 0001140361-23-034288 · form4.xml · derivative · entry 2 Wasman Jane · CIK 0001352455 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2033-05-26 F2 · derivative.exercise_date: The shares vest monthly over one (1) year from the date of grant, subject to the Reporting Person's continuous service on the Company's Board of Directors. Read SEC document |
| May 26, 2023 Filed Jul 12, 2023 22:45 UTC |
Wasman JaneDirector
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-034288 · form4.xml · nonDerivative · entry 1 Wasman Jane · CIK 0001352455 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 F1 · shares: The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors. Read SEC document |
| May 26, 2023 Filed Jul 12, 2023 22:45 UTC |
LYONS GARY ADirector
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $1.32 | $0.00 |
DisclosureSEC source: 0001140361-23-034287 · form4.xml · derivative · entry 2 LYONS GARY A · CIK 0001123343 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2033-05-26 F2 · derivative.exercise_date: The shares vest monthly over one (1) year from the date of grant, subject to the Reporting Person's continuous service on the Company's Board of Directors. Read SEC document |
| May 26, 2023 Filed Jul 12, 2023 22:45 UTC |
LYONS GARY ADirector
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-034287 · form4.xml · nonDerivative · entry 1 LYONS GARY A · CIK 0001123343 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 F1 · shares: The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors. Read SEC document |
| May 26, 2023 Filed Jul 12, 2023 22:45 UTC |
Ali-Jackson KamilDirector
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $1.32 | $0.00 |
DisclosureSEC source: 0001140361-23-034284 · form4.xml · derivative · entry 2 Ali-Jackson Kamil · CIK 0001654337 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2033-05-26 F2 · derivative.exercise_date: The shares vest monthly over one (1) year from the date of grant, subject to the Reporting Person's continuous service on the Company's Board of Directors. Read SEC document |
| May 26, 2023 Filed Jul 12, 2023 22:45 UTC |
Ali-Jackson KamilDirector
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-034284 · form4.xml · nonDerivative · entry 1 Ali-Jackson Kamil · CIK 0001654337 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,750 F1 · shares: The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors. Read SEC document |
| May 26, 2023 Filed Jul 12, 2023 22:45 UTC |
Kotzin Brian L.Director
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $1.32 | $0.00 |
DisclosureSEC source: 0001140361-23-034283 · form4.xml · derivative · entry 2 Kotzin Brian L. · CIK 0001715332 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2033-05-26 F2 · derivative.exercise_date: The shares vest monthly over one (1) year from the date of grant, subject to the Reporting Person's continuous service on the Company's Board of Directors. Read SEC document |
| May 26, 2023 Filed Jul 12, 2023 22:45 UTC |
Kotzin Brian L.Director
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-034283 · form4.xml · nonDerivative · entry 1 Kotzin Brian L. · CIK 0001715332 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 F1 · shares: The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors. Read SEC document |
| May 26, 2023 Filed Jul 12, 2023 22:45 UTC |
HANNAH ALISON L.Director
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $1.32 | $0.00 |
DisclosureSEC source: 0001140361-23-034282 · form4.xml · derivative · entry 2 HANNAH ALISON L. · CIK 0001645600 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2033-05-26 F2 · derivative.exercise_date: The shares vest monthly over one (1) year from the date of grant, subject to the Reporting Person's continuous service on the Company's Board of Directors. Read SEC document |
| May 26, 2023 Filed Jul 12, 2023 22:45 UTC |
HANNAH ALISON L.Director
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-034282 · form4.xml · nonDerivative · entry 1 HANNAH ALISON L. · CIK 0001645600 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,250 F1 · shares: The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors. Read SEC document |
| February 06, 2023 Filed Feb 7, 2023 21:30 UTC |
RODRIGUEZ RAUL RDirector · CEO, President
|
SaleCommon Stock | 20,340 | $1.75 | $35,595.00 |
DisclosureSEC source: 0001140361-23-005036 · form4.xml · nonDerivative · entry 2 RODRIGUEZ RAUL R · CIK 0001190279 · Director · CEO, President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,680,713 F3 · kind: These shares were sold to cover tax withholding due upon vesting of Restricted Stock Units. Such "sales to cover" were automatically effected to satisfy tax withholding obligations and do not represent a discretionary trade by the Reporting Person. Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 22:41 UTC |
Santos David AEVP, Chief Commercial Officer
|
SaleCommon Stock | 5,388 | $1.66 | $8,945.16 |
DisclosureSEC source: 0001140361-23-004733 · form4.xml · nonDerivative · entry 1 Santos David A · CIK 0001820066 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,612 F1 · kind: These shares were sold to cover tax withholding due upon vesting of Restricted Stock Units. Such "sales to cover" were automatically effected to satisfy tax withholding obligations and do not represent a discretionary trade by the Reporting Person. Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 22:40 UTC |
Schorno Dean LEVP & Chief Financial Officer
|
SaleCommon Stock | 5,389 | $1.66 | $8,946.28 |
DisclosureSEC source: 0001140361-23-004732 · form4.xml · nonDerivative · entry 1 Schorno Dean L · CIK 0001509688 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,519 F1 · kind: These shares were sold to cover tax withholding due upon vesting of Restricted Stock Units. Such "sales to cover" were automatically effected to satisfy tax withholding obligations and do not represent a discretionary trade by the Reporting Person. Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 22:40 UTC |
Dummer WolfgangEVP & CMO
|
SaleCommon Stock | 5,389 | $1.66 | $8,946.28 |
DisclosureSEC source: 0001140361-23-004731 · form4.xml · nonDerivative · entry 1 Dummer Wolfgang · CIK 0001749991 · EVP & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,459 F1 · kind: These shares were sold to cover tax withholding due upon vesting of Restricted Stock Units. Such "sales to cover" were automatically effected to satisfy tax withholding obligations and do not represent a discretionary trade by the Reporting Person. F2 · balance_after: Includes 10,000 shares acquired under the Issuer's stock purchase plan. Read SEC document |
| January 26, 2023 Filed Jan 31, 2023 02:45 UTC |
Dummer WolfgangEVP & CMO
|
GrantEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $2.42 | $0.00 |
DisclosureSEC source: 0001140361-23-003443 · form4.xml · derivative · entry 1 Dummer Wolfgang · CIK 0001749991 · EVP & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 50,000 shares Expires 2032-01-24 F1 · shares: The Reporting Person was granted an option with a performance-based condition with respect to 50,000 shares of common stock on January 24, 2022. Thus, the exercise price of this option is $2.42 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On January 26, 2023, it was determined that the performance metric had been met. F2 · derivative.exercise_date: The option was fully vested on January 26, 2023, the date the determination was made that the performance metric had been met. Read SEC document |
| January 26, 2023 Filed Jan 31, 2023 02:45 UTC |
RODRIGUEZ RAUL RDirector · CEO, President
|
GrantEmployee Stock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $2.42 | $0.00 |
DisclosureSEC source: 0001140361-23-003442 · form4.xml · derivative · entry 1 RODRIGUEZ RAUL R · CIK 0001190279 · Director · CEO, President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 200,000 shares Expires 2032-01-24 F1 · shares: The Reporting Person was granted an option with a performance-based condition with respect to 200,000 shares of common stock on January 24, 2022. Thus, the exercise price of this option is $2.42 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On January 26, 2023, it was determined that the performance metric had been met. F2 · derivative.exercise_date: The option was fully vested on January 26, 2023, the date the determination was made that the performance metric had been met. Read SEC document |
| January 26, 2023 Filed Jan 31, 2023 02:45 UTC |
Schorno Dean LEVP & Chief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 125,000 | $0.00 Strike: $1.87 | $0.00 |
DisclosureSEC source: 0001140361-23-003441 · form4.xml · derivative · entry 3 Schorno Dean L · CIK 0001509688 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2033-01-26 F5 · derivative.exercise_date: The shares of common stock subject to the option vest monthly over four (4) years from the vesting commencement date of January 1, 2023, subject to the Reporting Person's continuous service to the issuer through each such period. Read SEC document |
| January 26, 2023 Filed Jan 31, 2023 02:45 UTC |
Schorno Dean LEVP & Chief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $2.42 | $0.00 |
DisclosureSEC source: 0001140361-23-003441 · form4.xml · derivative · entry 2 Schorno Dean L · CIK 0001509688 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 50,000 shares Expires 2032-01-24 F3 · shares: The Reporting Person was granted an option with a performance-based condition with respect to 50,000 shares of common stock on January 24, 2022. Thus, the exercise price of this option is $2.42 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On January 26, 2023, it was determined that the performance metric had been met. F4 · derivative.exercise_date: The option was fully vested on January 26, 2023, the date the determination was made that the performance metric had been met. Read SEC document |
| January 26, 2023 Filed Jan 31, 2023 02:45 UTC |
Schorno Dean LEVP & Chief Financial Officer
|
GrantCommon Stock | 63,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-003441 · form4.xml · nonDerivative · entry 1 Schorno Dean L · CIK 0001509688 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,908 F1 · shares: The shares of common stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall vest annually over four (4) years from February 1, 2023, with the first annual vest occurring on February 1, 2024. F2 · balance_after: Includes 10,000 shares acquired under the issuer's stock purchase plan. Read SEC document |
| January 26, 2023 Filed Jan 31, 2023 02:45 UTC |
Santos David AEVP, Chief Commercial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 160,000 | $0.00 Strike: $1.87 | $0.00 |
DisclosureSEC source: 0001140361-23-003439 · form4.xml · derivative · entry 3 Santos David A · CIK 0001820066 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,000 Underlying: Common Stock · 160,000 shares Expires 2033-01-26 F5 · derivative.exercise_date: The shares of common stock subject to the option vest monthly over four (4) years from the vesting commencement date of January 1, 2023, subject to the Reporting Person's continuous service to the issuer through each such period. Read SEC document |
| January 26, 2023 Filed Jan 31, 2023 02:45 UTC |
Santos David AEVP, Chief Commercial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $2.42 | $0.00 |
DisclosureSEC source: 0001140361-23-003439 · form4.xml · derivative · entry 2 Santos David A · CIK 0001820066 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 50,000 shares Expires 2032-01-24 F3 · shares: The Reporting Person was granted an option with a performance-based condition with respect to 50,000 shares of common stock on January 24, 2022. Thus, the exercise price of this option is $2.42 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On January 26, 2023, it was determined that the performance metric had been met. F4 · derivative.exercise_date: The option was fully vested on January 26, 2023, the date the determination was made that the performance metric had been met. Read SEC document |
| January 26, 2023 Filed Jan 31, 2023 02:45 UTC |
Santos David AEVP, Chief Commercial Officer
|
GrantCommon Stock | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-003439 · form4.xml · nonDerivative · entry 1 Santos David A · CIK 0001820066 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 F1 · shares: The shares of common stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall vest annually over four (4) years from February 1, 2023, with the first annual vest occurring on February 1, 2024. F2 · balance_after: Includes 10,000 shares acquired under the issuer's stock purchase plan. Read SEC document |
| January 26, 2023 Filed Feb 7, 2023 21:30 UTC |
RODRIGUEZ RAUL RDirector · CEO, President
|
GrantEmployee Stock Option (right to buy) · Derivative | 600,000 | $0.00 Strike: $1.87 | $0.00 |
DisclosureSEC source: 0001140361-23-005036 · form4.xml · derivative · entry 3 RODRIGUEZ RAUL R · CIK 0001190279 · Director · CEO, President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600,000 Underlying: Common Stock · 600,000 shares Expires 2033-01-26 F4 · derivative.exercise_date: The shares of common stock subject to the option vest monthly over four (4) years from the vesting commencement date of January 1, 2023, subject to the Reporting Person's continuous service to the issuer through each such period. Read SEC document |
| January 26, 2023 Filed Feb 7, 2023 21:30 UTC |
RODRIGUEZ RAUL RDirector · CEO, President
|
GrantCommon Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-005036 · form4.xml · nonDerivative · entry 1 RODRIGUEZ RAUL R · CIK 0001190279 · Director · CEO, President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,701,053 F1 · shares: The shares of common stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall vest annually over four (4) years from February 1, 2023, with the first annual vest occurring on February 1, 2024. F2 · balance_after: Includes 9,277 shares acquired under the Issuer's stock purchase plan. Read SEC document |
| December 28, 2022 Filed Dec 30, 2022 21:30 UTC |
Santos David AEVP, Chief Commercial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $2.42 | $0.00 |
DisclosureSEC source: 0001140361-22-047667 · form4.xml · derivative · entry 1 Santos David A · CIK 0001820066 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2032-01-24 F1 · shares: The Reporting Person was granted an option with a performance-based condition with respect to 50,000 shares of common stock on January 24, 2022. Thus, the exercise price of this option is $2.42 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On December 28, 2022, it was determined that the performance metric had been met. F2 · derivative.exercise_date: The option was fully vested on December 28, 2022, the date the determination was made that the performance metric had been met. Read SEC document |
| December 28, 2022 Filed Dec 30, 2022 21:30 UTC |
RODRIGUEZ RAUL RDirector · CEO, President
|
GrantEmployee Stock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $2.42 | $0.00 |
DisclosureSEC source: 0001140361-22-047671 · form4.xml · derivative · entry 1 RODRIGUEZ RAUL R · CIK 0001190279 · Director · CEO, President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2032-01-24 F1 · shares: The Reporting Person was granted an option with a performance-based condition with respect to 200,000 shares of common stock on January 24, 2022. Thus, the exercise price of this option is $2.42 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On December 28, 2022, it was determined that the performance metric had been met. F2 · derivative.exercise_date: The option was fully vested on December 28, 2022, the date the determination was made that the performance metric had been met. Read SEC document |
| December 28, 2022 Filed Dec 30, 2022 21:30 UTC |
Dummer WolfgangEVP & CMO
|
GrantEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $2.42 | $0.00 |
DisclosureSEC source: 0001140361-22-047669 · form4.xml · derivative · entry 1 Dummer Wolfgang · CIK 0001749991 · EVP & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2032-01-24 F1 · shares: The Reporting Person was granted an option with a performance-based condition with respect to 50,000 shares of common stock on January 24, 2022. Thus, the exercise price of this option is $2.42 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On December 28, 2022, it was determined that the performance metric had been met. F2 · derivative.exercise_date: The option was fully vested on December 28, 2022, the date the determination was made that the performance metric had been met. Read SEC document |
| December 28, 2022 Filed Dec 30, 2022 21:30 UTC |
Schorno Dean LEVP & Chief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $2.42 | $0.00 |
DisclosureSEC source: 0001140361-22-047668 · form4.xml · derivative · entry 1 Schorno Dean L · CIK 0001509688 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2032-01-24 F1 · shares: The Reporting Person was granted an option with a performance-based condition with respect to 50,000 shares of common stock on January 24, 2022. Thus, the exercise price of this option is $2.42 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On December 28, 2022, it was determined that the performance metric had been met. F2 · derivative.exercise_date: The option was fully vested on December 28, 2022, the date the determination was made that the performance metric had been met. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 20:15 UTC |
VANCE DOLLYEVP Corp. Affairs, G.C., Sect.
|
GrantEmployee Stock Option (right to buy) · Derivative | 81,250 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001140361-22-033613 · form4.xml · derivative · entry 1 VANCE DOLLY · CIK 0001237676 · EVP Corp. Affairs, G.C., Sect. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,250 Underlying: Common Stock · 81,250 shares Expires 2029-01-23 F1 · shares: The reporting person was granted an option with a performance-based condition with respect to 81,250 shares of common stock on January 23, 2019. Thus, the exercise price of this option is $2.00 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On September 14, 2022, it was determined that the performance metric had been met. F2 · derivative.exercise_date: The option was fully vested on September 14, 2022, the date the determination was made that the performance metric had been met. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 20:15 UTC |
RODRIGUEZ RAUL RDirector · CEO, President
|
GrantEmployee Stock Option (right to buy) · Derivative | 300,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001140361-22-033612 · form4.xml · derivative · entry 1 RODRIGUEZ RAUL R · CIK 0001190279 · Director · CEO, President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2029-01-23 F1 · shares: The reporting person was granted an option with a performance-based condition with respect to 300,000 shares of common stock on January 23, 2019. Thus, the exercise price of this option is $2.00 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On September 14, 2022, it was determined that the performance metric had been met. F2 · derivative.exercise_date: The option was fully vested on September 14, 2022, the date the determination was made that the performance metric had been met. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 20:15 UTC |
Schorno Dean LEVP & Chief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 81,250 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001140361-22-033611 · form4.xml · derivative · entry 1 Schorno Dean L · CIK 0001509688 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,250 Underlying: Common Stock · 81,250 shares Expires 2029-01-23 F1 · shares: The reporting person was granted an option with a performance-based condition with respect to 81,250 shares of common stock on January 23, 2019. Thus, the exercise price of this option is $2.00 (the closing price of the issuer's common stock on Nasdaq the date of grant). In light of the performance-based vesting condition of this grant, the grant was not reportable under Section 16 until the performance metric was satisfied. On September 14, 2022, it was determined that the performance metric had been met. F2 · derivative.exercise_date: The option was fully vested on September 14, 2022, the date the determination was made that the performance metric had been met. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 20:36 UTC |
RODRIGUEZ RAUL RDirector · CEO, President
|
PurchaseCommon Stock | 1,000,000 | $0.69 | $688,400.00 |
DisclosureSEC source: 0001567619-22-012778 · doc1.xml · nonDerivative · entry 1 RODRIGUEZ RAUL R · CIK 0001190279 · Director · CEO, President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,391,776 F1 · price: The price reported in Column 4 is the weighted average price. These shares were purchased in multiple transactions ranging from $0.67 to $0.70. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the issuer, or the Securities and Exchange Commission, full information regarding the shares purchased at each such separate price. Read SEC document |
| May 20, 2022 Filed May 23, 2022 21:50 UTC |
MOOS WALTER HDirector
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $2.01 | $0.00 |
DisclosureSEC source: 0001140361-22-020308 · form4.xml · derivative · entry 2 MOOS WALTER H · CIK 0001190272 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2032-05-20 F2 · derivative.exercise_date: The shares vest monthly over one (1) year from the date of grant subject to the Reporting Person's continuous service on the Company's Board of Directors. Read SEC document |
| May 20, 2022 Filed May 23, 2022 21:50 UTC |
MOOS WALTER HDirector
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-020308 · form4.xml · nonDerivative · entry 1 MOOS WALTER H · CIK 0001190272 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,222 F1 · shares: The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors. Read SEC document |
| May 20, 2022 Filed May 23, 2022 21:50 UTC |
Wasman JaneDirector
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $2.01 | $0.00 |
DisclosureSEC source: 0001140361-22-020307 · form4.xml · derivative · entry 2 Wasman Jane · CIK 0001352455 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2032-05-20 F2 · derivative.exercise_date: The shares vest monthly over one (1) year from the date of grant subject to the Reporting Person's continuous service on the Company's Board of Directors. Read SEC document |
| May 20, 2022 Filed May 23, 2022 21:50 UTC |
Wasman JaneDirector
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-020307 · form4.xml · nonDerivative · entry 1 Wasman Jane · CIK 0001352455 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 F1 · shares: The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors. Read SEC document |
| May 20, 2022 Filed May 23, 2022 21:50 UTC |
LAPOINTE ANTHONY GREGGDirector
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $2.01 | $0.00 |
DisclosureSEC source: 0001140361-22-020306 · form4.xml · derivative · entry 2 LAPOINTE ANTHONY GREGG · CIK 0001331860 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2032-05-20 F2 · derivative.exercise_date: The shares vest monthly over one (1) year from the date of grant subject to the Reporting Person's continuous service on the Company's Board of Directors. Read SEC document |
| May 20, 2022 Filed May 23, 2022 21:50 UTC |
LAPOINTE ANTHONY GREGGDirector
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-020306 · form4.xml · nonDerivative · entry 1 LAPOINTE ANTHONY GREGG · CIK 0001331860 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 F1 · shares: The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.